Form 4: Shirley A. Weis Reports Changes in Beneficial Ownership of Pediatrix Medical Group, Inc. Stock

Director Shirley A. Weis reports acquisition and disposal of Pediatrix Medical Group, Inc. stock, including restricted shares granted under the company's incentive plan.

Summary

• Shirley A. Weis, a director of Pediatrix Medical Group, Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
• On May 8, 2025, Ms. Weis acquired 11,427 shares of common stock as part of an annual equity award, granted as restricted shares under the company's Amended and Restated 2008 Incentive Compensation Plan.
• These shares will vest on May 8, 2026.
• On the same day, Ms. Weis disposed of an unspecified amount of common stock.
• Following these transactions, Ms. Weis directly owns 29,787 shares of common stock.
• Additionally, 17,668 shares are indirectly held by The Weis Family Trust, for which Ms. Weis and her husband serve as trustees and her immediate family members are beneficiaries.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The acquisition of shares is a positive sign, but the disposal of shares introduces some uncertainty. Overall, it's a routine filing.

Positives

• The grant of restricted shares to a director signals confidence in the company's future performance.

Negatives

• The disposal of an unspecified amount of common stock by Ms. Weis could be interpreted negatively, although the reason for disposal is not provided.

Risks

• The Form 4 filing itself doesn't present any immediate risks, but the disposal of shares could be a point of concern if it signals a change in the director's outlook on the company.

Future Outlook

The document does not contain explicit forward-looking statements, but the granting of restricted shares suggests an expectation of continued service and contribution from the director.

Industry Context

Form 4 filings are a routine part of corporate governance and provide transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's sentiment and expectations regarding the company's performance.

Comparison to Industry Standards

• Comparing the equity compensation plans of Pediatrix Medical Group to those of similar healthcare companies like Envision Healthcare or AmSurg Corp. would provide context on whether the size and structure of the equity awards are in line with industry norms.
• Analyzing the vesting schedules and performance metrics attached to these awards can also reveal how Pediatrix incentivizes its directors compared to its peers.

Stakeholder Impact

• The transactions reported in the Form 4 may have a minor impact on shareholder sentiment, depending on how the market interprets the director's actions.

Key Dates

Keywords

beneficial ownership, Form 4, Pediatrix Medical Group, restricted shares, equity award, director, Weis, stock